Redmile Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Sell |
|
|||||
|
2025
Q1 | $31.4M | Buy |
|
|||||
|
2024
Q4 | $37.9M | Sell |
|
|||||
|
2024
Q3 | $39.5M | Sell |
|
|||||
|
2024
Q2 | $39.9M | Sell |
|
|||||
|
2024
Q1 | $62.1M | Buy |
|
|||||
|
2023
Q4 | $38.9M | Sell |
|
|||||
|
2023
Q3 | $35.3M | Sell |
|
|||||
|
2023
Q2 | $47.4M | Sell |
|
|||||
|
2023
Q1 | $49.4M | Sell |
|
|||||
|
2022
Q4 | $69.2M | Sell |
|
|||||
|
2022
Q3 | $84.5M | Sell |
|
|||||
|
2022
Q2 | $71.6M | Buy |
|
|||||
|
2022
Q1 | $105M | Sell |
|
|||||
|
2021
Q4 | $150M | Sell |
|
|||||
|
2021
Q3 | $172M | Sell |
|
|||||
|
2021
Q2 | $264M | Sell |
|
|||||
|
2021
Q1 | $203M | Sell |
|
|||||
|
2020
Q4 | $308M | Buy |
|
|||||
|
2020
Q3 | $81.9M | Sell |
|
|||||
|
2020
Q2 | $94M | Sell |
|
|||||
|
2020
Q1 | $60.5M | Buy |
|